Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...

Provides longer GLP-1 receptor activation. Depending on the medication, the effects can last for a minimum of 24 hours to a ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

For example, a starter dose of Novo’s Ozempic is 25 milligrams ... Hims' business has grown significantly, as have other ...

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

Insulin, which regulates blood sugar, is one example of a peptide hormone. Scientists have also created peptides in laboratories as treatments for various health conditions. Some of these peptide ...

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.